For the
quarter ending March 2022, consolidated net sales (including other operating income) of Apollo Hospitals Enterprise has increased 23.66% to Rs 3546.43 crore compared to quarter ended march 2021.
Operating profit margin has declined from 14.36% to 13.06%, leading to 12.48% rise in operating profit to Rs 463.24 crore. Raw material cost as a % of total sales (net of stock adjustments) increased from 15.86% to 16.01%. Purchase of finished goods cost fell from 35.60% to 35.32%. Employee cost decreased from 13.54% to 12.56%. Other expenses rose from 20.66% to 23.09%. Other income rose 50.22% to Rs 30.72 crore. PBIDT rose 14.27% to Rs 493.96 crore. Provision for interest fell 3.71% to Rs 94.9 crore. Loan funds declined from Rs 4,159.92 crore as of 31 March 2021 to Rs 4,068.12 crore as of 31 March 2022. Inventories rose to Rs 431.77 crore as of 31 March 2022 from Rs 249.48 crore as of 31 March 2021. Sundry debtors were higher at Rs 1,767.60 crore as of 31 March 2022 compared to Rs 1,331.12 crore as of 31 March 2021. Cash and bank balance rose to Rs 1,035.87 crore as of 31 March 2022 from Rs 724.40 crore as of 31 March 2021. Investments declined from Rs 1,342.66 crore as of 31 March 2021 to Rs 801.63 crore as of 31 March 2022. PBDT rose 19.58% to Rs 399.06 crore. Provision for depreciation rose 20.16% to Rs 166.4 crore. Fixed assets increased to Rs 7,391.47 crore as of 31 March 2022 from Rs 6,636.87 crore as of 31 March 2021. Intangible assets increased from Rs 375.32 crore to Rs 923.49 crore. Profit before tax grew 19.17% to Rs 232.66 crore. Share of profit/loss was 82.36% lower at Rs 3.02 crore. Provision for tax was expense of Rs 138.67 crore, compared to Rs 67.67 crore. Effective tax rate was 58.84% compared to 28.49%. Minority interest increased 236.76% to Rs 6.87 crore. Net profit attributable to owners of the company decreased 46.30% to Rs 90.14 crore. Equity capital stood at Rs 71.89 crore as of 31 March 2022 to Rs 71.89 crore as of 31 March 2021. Per share face Value remained same at Rs 5.00. Promoters’ stake was 29.33% as of 31 March 2022 ,compared to 29.82% as of 31 March 2021 . Promoters pledged stake was 16.37% as of 31 March 2022 ,compared to 27.94% as of 31 March 2021 .
Full year results analysis.
Net sales (including other operating income) of Apollo Hospitals Enterprise has increased 38.85% to Rs 14662.64 crore. Operating profit margin has jumped from 10.77% to 14.90%, leading to 92.11% rise in operating profit to Rs 2,185.12 crore. Raw material cost as a % of total sales (net of stock adjustments) increased from 15.19% to 18.22%. Purchase of finished goods cost fell from 39.18% to 33.67%. Employee cost decreased from 14.98% to 12.12%. Other expenses rose from 20.00% to 21.16%. Other income rose 73.68% to Rs 78.14 crore. PBIDT rose 91.41% to Rs 2263.26 crore. Provision for interest fell 15.71% to Rs 378.64 crore. Loan funds declined from Rs 4,159.92 crore as of 31 March 2021 to Rs 4,068.12 crore as of 31 March 2022. Inventories rose to Rs 431.77 crore as of 31 March 2022 from Rs 249.48 crore as of 31 March 2021. Sundry debtors were higher at Rs 1,767.60 crore as of 31 March 2022 compared to Rs 1,331.12 crore as of 31 March 2021. Cash and bank balance rose to Rs 1,035.87 crore as of 31 March 2022 from Rs 724.40 crore as of 31 March 2021. Investments declined from Rs 1,342.66 crore as of 31 March 2021 to Rs 801.63 crore as of 31 March 2022. PBDT rose 157.05% to Rs 1884.62 crore. Provision for depreciation rose 4.81% to Rs 600.7 crore. Fixed assets increased to Rs 7,391.47 crore as of 31 March 2022 from Rs 6,636.87 crore as of 31 March 2021. Intangible assets increased from Rs 375.32 crore to Rs 923.49 crore. Profit before tax grew 702.20% to Rs 1,283.92 crore. Share of profit/loss was 854.55% higher at Rs 7.35 crore. Extraordinary items were increased to Rs 294.11 crore. Provision for tax was expense of Rs 477.02 crore, compared to Rs 84.7 crore. Effective tax rate was 30.09% compared to 38.24%. Net profit attributable to owners of the company increased 602.06% to Rs 1,055.61 crore. Equity capital stood at Rs 71.89 crore as of 31 March 2022 to Rs 71.89 crore as of 31 March 2021. Per share face Value remained same at Rs 5.00. Promoters’ stake was 29.33% as of 31 March 2022 ,compared to 29.82% as of 31 March 2021 . Promoters pledged stake was 16.37% as of 31 March 2022 ,compared to 27.94% as of 31 March 2021 . Cash flow from operating activities increased to Rs 1,615.65 crore for year ended March 2022 from Rs 1,273.48 crore for year ended March 2021. Cash flow used in acquiring fixed assets during the year ended March 2022 stood at Rs 657.17 crore, compared to Rs 295.49 crore during the year ended March 2021.
Other highlights
The Board recommended a dividend of Rs 11.75 per share (235%
of face value of Rs 5 per share) for the financial year ended 31st March 2022.
| Apollo Hospitals Enterprise : Consolidated Results | | | Quarter ended | Year ended |
|---|
| Particulars | 202203 | 202103 | Var.(%) | 202203 | 202103 | Var.(%) |
|---|
| Net Sales (including other operating income) | 3,546.43 | 2,867.95 | 23.66 | 14,662.64 | 10,560.01 | 38.85 | | OPM (%) | 13.06 | 14.36 | -130 bps | 14.90 | 10.77 | 413 bps | | OP | 463.24 | 411.83 | 12.48 | 2,185.12 | 1,137.41 | 92.11 | | Other Inc. | 30.72 | 20.45 | 50.22 | 78.14 | 44.99 | 73.68 | | PBIDT | 493.96 | 432.28 | 14.27 | 2,263.26 | 1,182.40 | 91.41 | | Interest | 94.90 | 98.56 | -3.71 | 378.64 | 449.22 | -15.71 | | PBDT | 399.06 | 333.72 | 19.58 | 1,884.62 | 733.18 | 157.05 | | Depreciation | 166.4 | 138.48 | 20.16 | 600.7 | 573.13 | 4.81 | | PBT | 232.66 | 195.24 | 19.17 | 1283.92 | 160.05 | 702.20 | | Share of Profit/(Loss) from Associates | 3.02 | 17.12 | -82.36 | 7.35 | 0.77 | 854.55 | | PBT before EO | 235.68 | 212.36 | 10.98 | 1291.27 | 160.82 | 702.93 | | EO Income | 0 | 25.2 | - | 294.11 | 60.65 | 384.93 | | PBT after EO | 235.68 | 237.56 | -0.79 | 1585.38 | 221.47 | 615.84 | | Taxation | 138.67 | 67.67 | 104.92 | 477.02 | 84.7 | 463.19 | | PAT | 97.01 | 169.89 | -42.90 | 1108.36 | 136.77 | 710.38 | | Minority Interest (MI) | 6.87 | 2.04 | 236.76 | 52.75 | -13.59 | PL | | Net profit | 90.14 | 167.85 | -46.30 | 1055.61 | 150.36 | 602.06 | | P/(L) from discontinued operations net of tax | 0 | 0 | - | 0 | 0 | - | | Net profit after discontinued operations | 90.14 | 167.85 | -46.30 | 1055.61 | 150.36 | 602.06 | | EPS (Rs)* | 6.27 | 10.48 | -40.15 | 59.83 | 7.60 | 687.41 | | | * EPS is on current equity of Rs 71.89 crore, Face value of Rs 5, Excluding extraordinary items. | | # EPS is not annualised | | bps : Basis points | | EO : Extraordinary items | | Figures in Rs crore | | Source: Capitaline Corporate Database |
|
|